Update on chronic pain management

IF 1.5 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Internal Medicine Journal Pub Date : 2025-02-06 DOI:10.1111/imj.16589
Paul Glare, Melani Mahendran, Andrew D. Weiss
{"title":"Update on chronic pain management","authors":"Paul Glare,&nbsp;Melani Mahendran,&nbsp;Andrew D. Weiss","doi":"10.1111/imj.16589","DOIUrl":null,"url":null,"abstract":"<p>Pain is a common presenting symptom to consultant physicians, both in the hospital and in the clinic or rooms. Biologically, pain serves as warning of tissue damage. But this is no longer the case when pain is present for months or years, especially when it has been fully investigated. There can be a substantial discrepancy between the magnitude of pain, disability and distress reported by a patient with chronic pain and the extent of tissue damage identified. From the 1990s until the mid-2010s, opioids were promoted as a safe and effective panacea for chronic non-cancer pain. This led to overprescribing with unfortunate consequences of misuse, abuse and overdose deaths. The response to the so-called ‘opioid epidemic’ has led to a renewed focus on how chronic pain should be managed. The aim of this article is to update fellows and trainees on the assessment and management of chronic pain in adult medical patients. In particular, we address the role of pharmacotherapy post-opioid epidemic (primarily antidepressants and anticonvulsants in neuropathic pain), the place of interventional procedures and the nature and effectiveness of pain self-management training in people with chronic pain, many of whom have had pain for a year or more and failed other treatments.</p>","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":"55 2","pages":"200-206"},"PeriodicalIF":1.5000,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/imj.16589","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Internal Medicine Journal","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/imj.16589","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Pain is a common presenting symptom to consultant physicians, both in the hospital and in the clinic or rooms. Biologically, pain serves as warning of tissue damage. But this is no longer the case when pain is present for months or years, especially when it has been fully investigated. There can be a substantial discrepancy between the magnitude of pain, disability and distress reported by a patient with chronic pain and the extent of tissue damage identified. From the 1990s until the mid-2010s, opioids were promoted as a safe and effective panacea for chronic non-cancer pain. This led to overprescribing with unfortunate consequences of misuse, abuse and overdose deaths. The response to the so-called ‘opioid epidemic’ has led to a renewed focus on how chronic pain should be managed. The aim of this article is to update fellows and trainees on the assessment and management of chronic pain in adult medical patients. In particular, we address the role of pharmacotherapy post-opioid epidemic (primarily antidepressants and anticonvulsants in neuropathic pain), the place of interventional procedures and the nature and effectiveness of pain self-management training in people with chronic pain, many of whom have had pain for a year or more and failed other treatments.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
慢性疼痛管理的最新进展。
无论是在医院还是在诊所或病房,疼痛都是会诊医师常见的症状。从生物学上讲,疼痛是组织损伤的警告。但是,当疼痛持续数月或数年时,情况就不再是这样了,尤其是当疼痛已经得到充分调查后。慢性疼痛患者报告的疼痛、残疾和痛苦程度与确定的组织损伤程度之间可能存在实质性差异。从20世纪90年代到2010年代中期,阿片类药物被宣传为治疗慢性非癌症疼痛的安全有效的灵丹妙药。这导致了处方过度,导致了误用、滥用和过量死亡的不幸后果。对所谓的“阿片类药物流行”的反应使人们重新关注如何管理慢性疼痛。这篇文章的目的是更新研究员和学员对成人医疗患者慢性疼痛的评估和管理。特别是,我们讨论药物治疗后阿片类药物流行(主要是神经性疼痛的抗抑郁药和抗惊厥药)的作用,介入程序的地位以及慢性疼痛患者疼痛自我管理培训的性质和有效性,其中许多人已经疼痛了一年或更长时间,并且其他治疗失败。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Internal Medicine Journal
Internal Medicine Journal 医学-医学:内科
CiteScore
3.50
自引率
4.80%
发文量
600
审稿时长
3-6 weeks
期刊介绍: The Internal Medicine Journal is the official journal of the Adult Medicine Division of The Royal Australasian College of Physicians (RACP). Its purpose is to publish high-quality internationally competitive peer-reviewed original medical research, both laboratory and clinical, relating to the study and research of human disease. Papers will be considered from all areas of medical practice and science. The Journal also has a major role in continuing medical education and publishes review articles relevant to physician education.
期刊最新文献
Insights into omalizumab use in Auckland City Hospital's immunology 2023 chronic spontaneous urticaria cohort. Alcohol use disorder: an Australian perspective on screening, diagnosis, treatment and prevention. Steroid refractory desquamative interstitial pneumonia responsive to intravenous cyclophosphamide. Early outcomes from a new multidisciplinary cardiometabolic clinic: real-world experience in lowering low-density lipoprotein cholesterol. Albuminuria testing rates in people with diabetes, Victoria, 2022-2024: analysis of a pathology dataset.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1